Nasdaq Lists Two New ProShares ETFs
June 23 2015 - 9:02AM
Expands World's
Largest Lineup of Geared ETFs
Offers Leveraged
and Inverse Exposure to Biotech Companies
NEW YORK, June 23, 2015 (GLOBE NEWSWIRE) -- Today
Nasdaq announced that ProShares will list two new exchange-traded
funds (ETFs), UltraPro Nasdaq Biotechnology ETF (Symbol: UBIO) and
UltraPro Short Nasdaq Biotechnology ETF (Symbol: ZBIO), which will
both begin trading today, June 23, 2015. Both funds track the
Nasdaq Biotechnology Index.
"We're pleased to expand our suite of biotech ETFs
listed on Nasdaq," said Michael L. Sapir, cofounder and CEO of
ProShares Advisors, LLC, advisor to ProShares. "We now offer
investors four ETFs providing magnified or inverse exposure to the
Nasdaq Biotechnology Index, including the first and only 3x ETF on
the index."
ProShares is the world's largest provider of
geared ETFs. Geared ETFs are designed to offer knowledgeable
investors the opportunity to act on their views, whether it's
hedging against downturns with inverse ETFs or using a leveraged
ETF to get magnified exposure to a benchmark.
UBIO seeks to provide 3x and ZBIO seeks to provide
-3x the daily performance of the Nasdaq Biotechnology Index, before
fees and expenses. The Nasdaq Biotechnology Index is a modified
capitalization weighted index that includes Nasdaq-listed companies
classified as either biotechnology or pharmaceutical.
"We are thrilled to add UBIO and ZBIO to the
ProShares product suite listed on The Nasdaq Stock Market," said
Jeff McCarthy, Vice President and Head of ETP Listings at Nasdaq.
"These two products join the ProShares Ultra Nasdaq Biotechnology
ETF (Symbol: BIB) and ProShares UltraShort Nasdaq Biotechnology ETF
(Symbol: BIS), all benchmarked to the Nasdaq Biotechnology Index
(Symbol: NBI). These launches demonstrate how Nasdaq can provide
clients with turn-key solutions for passive products supporting
both listing and index strategy."
Nasdaq operates an efficient platform for
successfully introducing a product suite into one of the single
largest pools of liquidity, including market participants which
represent a full spectrum of investors. ETF issuers benefit from an
end-to-end solution that provides ongoing product support including
index licensing, listings opportunities, data offerings and trading
services. As the home to some of the world's most innovative
ventures, Nasdaq generates opportunities for issuers to access new
markets and deliver new concepts that change the way the industry
develops, manages and applies ETFs.
About ProShares:
ProShares offers the nation's largest lineup of
alternative ETFs. They help investors to go beyond the limitations
of conventional investing and face today's market challenges.
ProShares helps investors build better portfolios by providing
access to alternative investments delivered with the liquidity,
transparency and cost effectiveness of ETFs. Their wide array of
alternative ETFs can help you reduce volatility, manage risk and
enhance returns.
About Nasdaq:
Nasdaq (Nasdaq:NDAQ) is a leading provider of
trading, clearing, exchange technology, listing, information and
public company services across six continents. Through its diverse
portfolio of solutions, Nasdaq enables customers to plan, optimize
and execute their business vision with confidence, using proven
technologies that provide transparency and insight for navigating
today's global capital markets. As the creator of the world's
first electronic stock market, its technology powers more than 70
marketplaces in 50 countries, and 1 in 10 of the world's securities
transactions. Nasdaq is home to more than 3,500 listed companies
with a market value of approximately $9.5 trillion and more than
10,000 corporate clients. To learn more, visit: nasdaq.com/ambition
or business.nasdaq.com.
Cautionary Note Regarding
Forward-Looking Statements
The matters described herein
contain forward-looking statements that are made under the Safe
Harbor provisions of the Private Securities Litigation Reform Act
of 1995. These statements include, but are not limited to,
statements about Nasdaq and its products and offerings. We caution
that these statements are not guarantees of future performance.
Actual results may differ materially from those expressed or
implied in the forward-looking statements. Forward-looking
statements involve a number of risks, uncertainties or other
factors beyond Nasdaq's control. These factors include, but are not
limited to factors detailed in Nasdaq's annual report on Form 10-K,
and periodic reports filed with the U.S. Securities and Exchange
Commission. We undertake no obligation to release any revisions to
any forward-looking statements.
Nothing contained herein should be construed as
investment advice from Nasdaq, either on behalf of a particular
financial product or an overall investment strategy. Nasdaq makes
no recommendation to buy or sell any financial product or any
representation about the financial condition of any company or
fund. Investors should undertake their own due diligence and
carefully evaluate financial products before investing. ADVICE FROM
A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
NDAQG
CONTACT: ProShares Media Contact:
Tucker
Hewes
Hewes
Communications, Inc.
+1 (212) 207-9451
(office)
tucker@hewescomm.com
Nasdaq Media
Contact:
Alexa
Sugrue
+1 (212) 231-5552
(office)
+1 (646) 577-3157
(mobile)
Alexa.Sugrue@nasdaq.com
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: The NASDAQ OMX Group, Inc. via Globenewswire
HUG#1930705
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Apr 2023 to Apr 2024